SIMVASTATIN | A200895 | HETERO LABS LTD UNIT III
Highest NADAC/Unit
$0.0908
per ea
Lowest NADAC/Unit
$0.0278
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 82009001605SIMVASTATIN 80 MG TABLET | $0.0908 | EA | Generic | — | 2026-10-21 |
| 31722051490SIMVASTATIN 80 MG TABLET | $0.0908 | EA | Generic | — | 2026-10-21 |
| 82009001510SIMVASTATIN 40 MG TABLET | $0.0523 | EA | Generic | — | 2026-10-21 |
| 82009001410SIMVASTATIN 20 MG TABLET | $0.0324 | EA | Generic | — | 2026-10-21 |
| 82009001210SIMVASTATIN 5 MG TABLET | $0.0315 | EA | Generic | — | 2026-10-21 |
| 31722051010SIMVASTATIN 5 MG TABLET | $0.0315 | EA | Generic | — | 2026-10-21 |
| 82009001310SIMVASTATIN 10 MG TABLET | $0.0278 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.